CGM Tracking
Continuous Glucose Monitoring for Metabolic Optimisation
Continuous glucose monitors (CGMs) are small wearable sensors that track blood glucose levels in real time, providing 24/7 data on how food, exercise, stress, and sleep affect metabolic health. Originally developed for diabetes management, CGMs (FreeStyle Libre, Dexcom G7, Levels) are increasingly used by non-diabetic biohackers and longevity enthusiasts to optimize metabolic function, prevent insulin resistance, and personalize nutrition. A growing trend in the UAE wellness and biohacking community.
How CGM Tracking Works
Continuous glucose monitors use a small filament inserted just under the skin that measures interstitial fluid glucose levels every 1-5 minutes via glucose oxidase enzyme reactions, generating an electrical signal proportional to glucose concentration. For non-diabetics using CGMs for metabolic optimisation, the data reveals individual glycaemic responses to specific foods, exercise, stress, and sleep. This enables personalised dietary choices that minimise postprandial glucose spikes (ideally keeping glucose below 140 mg/dL, with minimal time above 120 mg/dL). Stable glucose levels are associated with better energy, reduced inflammation, lower insulin resistance, and potentially reduced long-term chronic disease risk.
📊 Evidence by Outcome
CGM data reveals significant individual variation in glucose responses to identical foods, enabling personalized dietary choices. Hall et al. (2018) found substantial glucotype diversity even among non-diabetics, suggesting many nominally healthy individuals experience problematic glucose excursions.
18 studies • Consistency: High • Effect: Moderate
The landmark Zeevi et al. (2015) study demonstrated that individual glucose responses to identical meals vary enormously and are predictable using machine learning on personal data, validating the use of CGMs for personalized dietary guidance over generic recommendations.
12 studies • Consistency: Moderate • Effect: Moderate
While CGM use in non-diabetics is rational and increasingly popular, no long-term RCTs have demonstrated that CGM-guided behavior change in healthy individuals prevents diabetes or improves hard metabolic endpoints. The evidence base for non-diabetic use remains largely observational and mechanistic.
5 studies • Consistency: Low • Effect: None
Key Research
Peer-Reviewed Evidence • 3 Citations
Glucotypes reveal new patterns of glucose dysregulation
Hall H, Perelman D, Breschi A et al.•PLoS Biol•2018•PMID: 30054633
Key Finding: Used CGM to identify three distinct glucotypes (low, moderate, severe variability) in non-diabetic individuals, revealing that many ostensibly healthy people experience glucose dysregulation and pre-diabetic patterns.
View on PubMedPersonalized nutrition by prediction of glycemic responses
Zeevi D, Korem T, Zmora N et al.•Cell•2015•PMID: 26590418
Key Finding: Landmark study of 800 participants demonstrating that individual glycemic responses to identical meals are highly variable and can be predicted by a machine learning algorithm integrating CGM data, blood tests, dietary habits, and gut microbiome profiles.
View on PubMedContinuous glucose profiles in healthy subjects under everyday life conditions and after different meals
Freckmann G, Hagenlocher S, Bauer A et al.•J Diabetes Sci Technol•2007•PMID: 19885141
Key Finding: Established normative CGM profiles in healthy non-diabetic subjects, demonstrating that glucose levels remain between 70-140 mg/dL for the vast majority of the day but can spike above 140 mg/dL after high-glycemic meals even in healthy individuals.
View on PubMedCitations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.
Side Effects & Safety
Interactions & Contraindications
Drug Interactions
- •High-dose vitamin C (>500mg) can cause falsely elevated readings on some CGM sensors
- •Acetaminophen (paracetamol) may interfere with certain CGM sensor readings
- •Hydroxyurea affects some sensor technologies
Supplement Interactions
- •High-dose vitamin C can interfere with glucose oxidase-based sensors
- •Chromium and berberine supplements lower blood glucose, affecting CGM interpretation
Food & Timing
- •The entire purpose of CGM tracking is to observe food-glucose interactions
- •Individual glucose responses to identical foods vary by up to 5x between people
- •Meal order (fibre first, protein second, carbs last) consistently reduces glucose spikes
Who Should Avoid
- •History of eating disorders (glucose tracking may trigger obsessive food behaviours)
- •Severe skin conditions at potential sensor sites
- •Known allergy to sensor adhesive components
- •MRI scheduled (sensors must be removed before MRI in most cases)
- •Heavy anxiety around health metrics
📋 Protocol Snapshot
Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.
Cost Guide
AED 500-1,400/month
Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.
Frequently Asked Questions
Yes. Several wellness and longevity clinics in Dubai prescribe CGMs for metabolic optimisation in non-diabetics. Companies like Veri and Levels ship internationally. The FreeStyle Libre is available at many UAE pharmacies (AED 250-350 per 14-day sensor). Abbott's Lingo, designed specifically for non-diabetics, is also becoming available. Some integrative medicine practitioners include CGM tracking as part of metabolic health programmes.
A minimum of 2-4 weeks provides enough data to identify your personal glucose patterns and food responses. Many people benefit from 2-3 months initially to systematically test different meals, exercise timing, and lifestyle variables. After learning your patterns, periodic 2-week check-ins every 3-6 months can confirm that your metabolic health strategies are working.
Optimal targets for metabolic health: fasting glucose 70-90 mg/dL, post-meal peak below 120-140 mg/dL (returning to baseline within 2 hours), average glucose 80-100 mg/dL, and glucose variability (standard deviation) below 20 mg/dL. These are tighter than diabetic targets and reflect metabolic optimisation goals. Some experts argue these targets are unnecessarily strict for healthy individuals.
Opinions differ. Proponents argue that CGM data reveals hidden metabolic dysfunction and enables personalised nutrition. Sceptics note that healthy non-diabetics rarely have concerning glucose patterns, and the cost and potential for anxiety may outweigh benefits. The strongest case is for people with prediabetes, family history of diabetes, weight management goals, or those wanting to optimise athletic performance and energy levels.
Where to Get It (UAE)
Related Treatments
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.